Search

Author/Creator Crown, J.P.

1. 150P Phase I study of fianlimab: A human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced melanoma (mel) - Subgroup analysis. (December 2022)

Authors:
Hamid, O.; Lewis, K.; Weise, A.; McKean, M.; Papadopoulos, K.; Crown, J.P.; Thomas, S.; Kaczmar, J.; Lakhani, N.; Kim, T.M.; Kim, K.; Rabinowits, G.; Spira, A.S.; Mani, J.; Chen, S.; Gullo, G.
Journal:
Immuno-oncology technology
Issue:
Volume 16(2022)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Impact of palbociclib plus letrozole on pain severity and pain interference with daily activities in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer as first-line treatment. (3rd May 2016)

Authors:
Bell, T.; Crown, J.P.; Lang, I.; Bhattacharyya, H.; Zanotti, G.; Randolph, S.; Kim, S.; Huang, X.; Huang Bartlett, C.; Finn, R.S.; Slamon, D.
Journal:
Current medical research and opinion
Issue:
Volume 32:Number 5(2016:May)
Page Start:
959
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P008 Real-world analysis of the clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage node positive breast cancer in Ireland. (April 2023)

Authors:
Browne, I.M.; McLaughlin, R.A.; Prichard, R.S.; McCartan, D.P.; Millen, S.J.; Higgins, M.J.; Crown, J.P.; Hennessy, B.T.; Quinn, C.M.; Morris, P.G.; Walshe, J.M.
Journal:
Breast
Issue:
Volume 68(2023)Supplement
Page Start:
S18
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗